Active Digestion, Kidneys & Other Organs NIHR-supported project Cancer

BOOST hydroxy-methylbutyrate (HMB) supplementation to improve functional status in people with advanced liver cirrhosis: a phase IV multicentre double-blind placebo-controlled randomised trial with embedded qualitative study

Funder NIHR (part of DHSC)
Recipient organisation NIHR Nottingham Biomedical Research Centre
NIHR support Recorded as supported by this research centre
Period Jan 2025 — Dec 2026

About this grant

This summary is based on the grant title only — the full abstract was not available.

No substantive source abstract was published for this research project funded by NIHR.

Researchers

Naaventhan Palaniyappan (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

?-hydroxy ?-methylbutyrate (HMB) supplementation to improve functional status in people with advanced liver cirrhosis: a multicentre double blind placebo-controlled randomised trial
B-hydroxy-methylbutyrate (HMB) supplementation to improve functional status in people with advanced liver cirrhosis
?-hydroxy ß-methylbutyrate (HMB) supplementation to optimise outcomes in advanced liver cirrhosis (BOOST): a multicentre double blind placebo-controlled randomised trial
BMS IM025-017: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Dose Phase 2 Study to Evaluate the Efficacy and Safety of BMS-986263 in Adults with Compensated Cirrhosis from Nonalcoholic Steatohepatitis
IM025-017 - A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Dose Phase 2 Study to Evaluate the Efficacy and Safety of BMS-986263 in Adults with Compensated Cirrhosis from Nonalcoholic Steatohepatitis (NASH)

Original classification

Gastrointestinal and Liver Disorders

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.